A Minireview of ADHD Pharmacotherapy

編者評論：過動症的藥物治療

張勝傑(Shen-Chieh Chang)

台灣精神醫學

28卷4期（2014 / 12 / 01）

207 - 210

英文

1. Arnsten, AF(2010).The use of α-2A adrenergic agonists for the treatment of attention-defi cit/hyperactivity disorder.Expert Rev Neurother,10,1595-605.
2. Childress, AC,Sallee, FR(2014).Attention-deficit/hyperactivitydisorder with inadequate response to stimulants: approaches to management.CNS Drugs,28,121-9.
3. Garnock-Jones, KP,Keating, GM(2009).Atomoxetine: a review of its use in attention-defi cit hyperactivity disorder in children and adolescents.Paed Drugs,11,203-26.
4. Hirota, T,Schwartz, S,Correll, CU(2014).Alpha-2 agonists for attention-defi cit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.J Am Acad Child Adolesc Psychiatry,53,153-73.
5. Koda, K,Ago, Y,Cong, Y,Kita, Y,Takuma, K,Matsuda, T(2010).Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.J Neurochem,114,259-70.
6. Kumar, R(2008).Approved and investigational uses of modafi nil: an evidence-based review..Drugs,68,1803-39.
7. Maneeton, N,Maneeton, B,Intaprasert, S,Woottiluk, P(2014).A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment ofattention-defi cit/hyperactivity disorder.Neuropsychiatr Dis Treat,10,1439-49.
8. Marcus, SC,Wan, GJ,Kemner, JE,Olfson, M(2005).Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.Arch Pediatr Adolesc Med,159,572-8.
9. Otasowie, J,Castells, X,Ehimare, UP,Smith, CH(2014).Tricyclic antidepressants for attention defi cit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev,9,CD006997.
10. Park, P,Caballero, J,Omidian, H(2014).Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-defi cit hyperactivity disorder in pediatrics.Ann Pharmacother,48,86-92.
11. Pliszka, S,AACAP Work Group on Quality Issues(2007).Practice parameter for the assessment and treatment of children and adolescents with attention-defi cit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry,46,894-921.
12. Pliszka, SR,Crismon, ML,Hughes, CW(2006).Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder: The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-defi cit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry,45,642-57.
13. Potter, AS,Schaubhut, G,Shipman, M.Targeting the nicotinic cholinergic system to treat attention-defi cit/hyperactivity disorder: rationale and progress to date.CNS Drugs
14. Sadack, BJ,Sadock, VA,Ruiz, P(2014).Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry.Philedelphia:Lippincott Williams & Wilkins.
15. Scahill, L(2009).Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.CNS Drugs,23(Suppl 1),S43-9.
16. Stahl, SM.(2013).Stahl's Essential Psychopharmacology.New York:Cambridge University Press.
17. Subcommittee on Attention-Deficit/Hyperactivity Disorder,Steering Committee on Quality Improvement and Management,Wolraich, M(2011).Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.Pediatrics,128,1007-22.
18. The MTA cooperative group(1999).A 14-month randomized clinical trial of treatment strategies for attentiondeficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD..Arch Gen Psychiatry,56,1073-86.